Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of LY2062430 on the Progression of Alzheimer's Disease (EXPEDITION2)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Eli Lilly and Company
ClinicalTrials.gov Identifier:
NCT00904683
First received: May 18, 2009
Last updated: December 11, 2012
Last verified: December 2012